NIH Directors New Innovator Award (DP2 Clinical Trial Optional)

The NIH Director's New Innovator Award is administered by the National Institutes of Health within the U.S. Department of Health and Human Services as part of the NIH Common Fund High Risk High Reward Research program. This initiative is designed to support early stage investigators who demonstrate exceptional creativity and propose bold, innovative research with the potential to significantly impact broad areas of biomedical science. The program emphasizes innovation over preliminary data and aims to provide opportunities for investigators who may not yet be competitive in traditional grant mechanisms. The purpose of the award is to stimulate highly innovative research approaches that address important biomedical challenges aligned with the NIH mission. Projects may span basic, translational, or clinical research domains and are expected to push beyond current scientific boundaries. The award is structured to encourage risk taking and flexibility, allowing recipients to adjust research directions over the project period in order to maximize scientific impact. This flexibility distinguishes the program from conventional NIH funding mechanisms that typically require detailed experimental plans. Funding supports a wide range of allowable costs including personnel, equipment, supplies, data management, and other research related expenses. Awards provide up to four hundred seventy five thousand dollars in direct costs annually over a five year project period, totaling up to two million three hundred seventy five thousand dollars in direct funding. Indirect costs are provided separately in accordance with NIH policy. The program does not require cost sharing or matching funds. Funds must be used in alignment with federal grant regulations and NIH policy guidelines. Eligibility is limited to early stage investigators who have completed their terminal degree or clinical training within the past ten years and have not previously received a substantial independent NIH research award. Applicants must hold or secure an independent research position at a U.S. based institution by September one, two thousand twenty seven. Eligible organizations include a broad range of U.S. entities such as institutions of higher education, nonprofits, for profit organizations, and government entities. Foreign organizations are not eligible to apply, although certain non funded collaborations may be permitted. Applications must be submitted electronically through Grants dot gov using systems such as ASSIST, Workspace, or institutional submission tools, with tracking managed through eRA Commons. Applicants are required to follow detailed instructions outlined in the NIH application guide, including submission of a research strategy essay focused on innovation, impact, and investigator capability rather than traditional detailed experimental design. Required components include organizational registrations, investigator credentials, data management plans, and compliance with all NIH submission requirements. Applications are evaluated through a two phase peer review process emphasizing the significance of the research problem, the novelty of the approach, and the creativity and potential of the investigator. Reviewers assess the likelihood that the proposed work will produce substantial impact on biomedical research. The process includes scientific merit review followed by advisory council review, with final funding decisions based on merit, program priorities, and available funds. Key dates include an application opening on July seventeen, two thousand twenty six, and a submission deadline of August seventeen, two thousand twenty six. Awards are expected to begin in July two thousand twenty seven following review cycles completed in early two thousand twenty seven. The program is offered annually as part of the NIH High Risk High Reward Research portfolio, with future cycles anticipated based on similar timelines. Applicants may contact program staff via the provided NIH email address for questions or attend pre application webinars for guidance on submission and review expectations.

Focus on bold innovative ideas rather than preliminary data; emphasize creativity and high impact potential; clearly demonstrate independence and capability as an early stage investigator